US 11338041
Exon skipping oligomer conjugates for muscular dystrophy
granted A61KA61K47/6455A61K47/6807
Quick answer
US patent 11338041 (Exon skipping oligomer conjugates for muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K47/6455, A61K47/6807, A61K9/0019